Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$392.81 - $485.53 $3.54 Million - $4.37 Million
9,000 Added 37.5%
33,000 $15.5 Million
Q1 2024

May 15, 2024

BUY
$407.69 - $446.08 $9.78 Million - $10.7 Million
24,000 New
24,000 $10 Million
Q4 2023

Feb 14, 2024

BUY
$343.0 - $410.68 $9.26 Million - $11.1 Million
27,000 New
27,000 $11 Million
Q2 2023

Aug 14, 2023

BUY
$314.42 - $351.91 $1.51 Million - $1.69 Million
4,800 New
4,800 $1.69 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Nomura Holdings Inc Portfolio

Follow Nomura Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.